The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.

Anita MacDonaldRachel WebsterMatthew WhitlockAdam GerrardAnne DalyMary Anne PreeceSharon EvansCatherine AshmoreAnupam ChakrapaniSuresh VijaySaikat Santra

Published in: Journal of pediatric endocrinology & metabolism : JPEM (2018)

This is the first safety trial reported of an MCT formula specifically designed for infants and children with LCFAOD. In this short-term study, it appeared safe and well tolerated in this challenging group.

Keyphrases

fatty acid
clinical trial
study protocol
randomized controlled trial
phase iii
phase ii
double blind
low density lipoprotein